EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients

Anil Chandraker, Gabardi, Martin, Tsapepas

Transplant Research and Risk Management · 2011

DOI: 10.2147/trrm.s11538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Research and Risk Management, 2011. Verfasst von Anil Chandraker und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chandraker, A., Gabardi, Martin, & Tsapepas (2011). Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients. Transplant Research and Risk Management. https://doi.org/10.2147/trrm.s11538

Vancouver

Chandraker A, Gabardi, Martin, Tsapepas. Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients. Transplant Research and Risk Management. 2011. doi:10.2147/trrm.s11538

BibTeX
@article{Chandraker2011,
  author = {Chandraker, Anil and Gabardi and Martin and Tsapepas},
  title = {Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients},
  journal = {Transplant Research and Risk Management},
  year = {2011},
  doi = {10.2147/trrm.s11538}
}
Kostenlos starten →